MARKERS OF BONE METABOLISM IN LONG BONE’S ADHESION

Abstract


This review presents the current evidence about the use of markers of bone metabolism in the prediction of fracture healing, differences in concentrations of blood markers of bone metabolism in patients with normal and delayed consolidation of bone fragments. We analyze the relationship between the fracture site, time-stage features of its healing and urinary macromolecules, reflecting bone metabolism. Increase in bone turnover, which is observed after the fracture, is characterized by activation markers of bone resorption, with a subsequent increase in the concentration of blood markers of bone formation. However, there is a marked variability in data concerning the levels of bone markers in plasma at different stages of fracture healing. We show that in patients with delayed fracture healing there is a significant delay in raising osteocalcin levels. Prognostic features for determining fracture nonunion include low concentrations of N-terminal propeptide of procollagen type I. Determination of markers of bone metabolism in blood can serve as informative criterion for the course of reparative osteogenesis, but one must consider the nature of traumatic injury, time passed from injury, especially the state of bone tissue at the time of injury, age of the patient to identify the early stages of consolidation disturbances.

E A Pobel

assistent kafedry travmatologii i ortopedii, kand. med. nauk

L M Bengus

vedushchiy nauchn. sotrudnik laboratorii morfologii soedinitel'noy tkani, kand. biol. nauk

N V Dedukh

Email: dedukh_ninel@ukr.net
zaveduyushchaya laboratoriey morfologii soedinitel'noy tkani, professor.

  1. Cox G., Einhorn T. Tsioupis A.C., Giannoudis P.V. Bone-turnover markers in fracture healing // J. Bone Jnt. Surg — 2010. — V. 92-B., Iss. 3 — P. 329-334.
  2. Ingle B.M., Hay S. M., Bottjer H. M., Eastell R. Changes in bone mass and bone turnover following distal forearm fracture // Osteoporosis International. — 1999. — V. 10, № 5. — 399-407.
  3. Takahara K., Kamimura M., Nakagawa H., Shigeharu U. Changes in biochemical markers of bone in patients with insufficiency fractures // Journal of Bone and Mineral Metabolism. — 2004. — V. 22, № 6. — P. 618-625.
  4. Singer F.R., Eyre D.R. Using biochemical markers of bone turnover in clinical practice // Cleveland Clinic Journal Of Medicine — 2008. — Vol. 75, № 10. — P. 739-750.
  5. Epstein S. Serum and urinary markers of bone remodeling: assessment of bone turnover // Endocrine Reviews. — 1998. — V. 9. — P. 437-448.
  6. Bone Alkaline Phosphatase in Serum // |NHANES. — 2003-2004. — P. 2-15.
  7. Hale L.V., Galvin R.J., Risteli J., Ma Y.L., Harvey A.K., Yang X., Cain R.L., Zeng Q., Frolik C.A., Sato M., Schmidt A.L., Geiser A.G. PINP: a serum biomarker of bone formation in the rat // J Bone Miner Res. — 2007. — V. 40, № 4. — P. 1103-1109.
  8. Ivaska K.K., Hentunen T.A., Vaaraniemi J., Ylipahkala H., Pettersson K., Vaananen H.K. Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro // J. Biol. Chem. — 2004. — V. 279, № 18. — P. 18361-18369.
  9. Baumgrass R., Williamson M.K., Price P.A. Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B., D., L., H., and S. // J. Bone Miner. Res. — 1997. — V. 12. — P. 447-455.
  10. Pedersen B.J., Schlemmer A., Hassager C., Christiansen C. Changes in the carboxyl-terminal propeptide of type I procollagen and other markers of bone formation upon five days of bed rest // Bone. — 1995. — V. 17, № 1. — P. 91-95.
  11. Melkko J., Kauppila S., Niemi S., Risteli L., Haukipuro K., Jukkola A., Risteli J. Immunoassay for intact amino-terminal propeptide of human type I procollagen // Clin. Chem. — 1996. — V. 42, № 6. — P. 947-954.
  12. Eriksen E.F., Charles P., Melsen F., Mosekilde L., Risteli L., Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry // J. Bone Miner. Res. — 1993. — V. 8, № 2. — P. 127-132.
  13. Hassager C., Jensen L.T., Johansen J.S., et al. The carboxyterminal propeptide of type 1 procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones // Metabolism. — 1991. — V. 40. — P. 205-208.
  14. Linkhart S.G., Linkhart T.A., Taylor A.K., Wergedal J.E., Bettica P., Baylink D.J. Synthetic peptidebased immunoassay for amino-terminal propeptide of type I procollagen: application for evaluation of bone formation // Clin. Chem. — 1993. — V. 39, № 11. — P. 2254-2258.
  15. Seibel M. Biochemical markers of bone turnover: part I: biochemistry and variability // Clin. Biochem. Rev. — 2005. — V. 26. — P. 97-122.
  16. Coulibaly M.O., Sietsema D.L., Burgers T.A., Mason J., Williams B.O., Jones C.B. Recent advances in the use of serological bone formation markers to monitor callus development and fracture healing // Crit Rev Eukaryot Gene Expr. — 2010. — V. 20, № 2. — P. 105-127.
  17. Han B., Copeland M., Geiser A.G., Hale L.V., Harvey A., Ma Y.L., Powers C.S., Sato M., You J., Hale J.E. Development of a highly sensitive, high-throughput, mass spectrometry-based assay for rat procollagen type-I N-terminal propeptide (PINP) to measure bone formation activity // J. Proteome Res. — 2007. — V. 6, № 11. — P. 4218-4229.
  18. Adami S., Gatti D., Viapiana O., Fiore C.E., Nuti R., Luisetto G., Ponte M., Rossini M. Physical activity and bone turnover markers: a cross-sectional and a longitudinal study // Calcif. Tissue Int. — 2008. — V. 83, № 6. — P. 388-392.
  19. Komi J., Lankinen K.S., DeGregorio M., Heikkinen J., Saarikoski S., Tuppurainen M., Halonen K., Lammintausta R., Vaananen K., Ylikorkala O., Erkkola R. Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women // J. Bone Miner. Metab. — 2006. — V. 24, № 4. — P. 314-318.
  20. Miller P.D., Schwartz E.N., Chen P., Misurski D.A., Krege J.H. Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment // Osteoporos Int. — 2007. — V. 18, № 1. — P. 59-68.
  21. Watts N.B., Miller P.D., Kohlmeier L.A., Sebba A., Chen P., Wong M., Krohn K. Vertebral fracture risk is reduced in women who lose femoral neck BMD with teriparatide treatment // J. Bone Miner Res. — 2009. — V. 24, № 6. — P. 1125-1131.
  22. Body J.J., Lichinitser M., Tjulandin S., Garnero P., Bergstrom B. Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases // Ann Oncol. — 2007. — V. 18, № 7. — 1165-1171.
  23. Lein M., Miller K., Wirth M., Weissbach L., May C., Schmidt K., Haus U., Schrader M., Jung K. Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid // Prostate. — 2009. — V. 69, № 6. — P. 624-632.
  24. Cloos P.A.C., Fledelius C., Ovist P., Garnero P. Biological clocks of bone aging: race misation and isomerization, potential tools to assess bone turnover // Bone. — 1998. — V. 23 (Suppl.) — F440.
  25. Hanson D.A., Weis M.A., Bollen A.M., Maslan S.L., Singer F.R., Eyre D.R. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine // J. Bone Miner. Res. — 1992. — V. 7. — P. 1251-1258.
  26. Garnero P. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring // Mol. Diagn. Ther. — 2008. — V. 12, № 3. — P. 157-170.
  27. Garnero P., Fledelius C., Gineyts E., et al. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha chain in Paget‘s disease of bone // J. Bone Miner. Res. — 1997. — V. 12. — P. 1407-1415.
  28. Robins S.P. Fibrillogenesis and maturation of collagens. In: dynamics of bone and cartilage metabolism, Seibel M.J., Robins S.P., Bilezikian J.P. eds. — San Diego: Academic Press, 1999. — P. 31-42.
  29. von der Mark K., Seibel M., Robins S., Bilezikian J eds. Structure and biosynthesis of collagens. in: dynamics of bone and car tilage metabolism. — San Diego: Academic Press, 1999. — P. 3-30.
  30. Delmas P.D., Schlemmer A., Gineyts E., et al. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis // J. Bone Miner. Res. — 1991. — V. 6. — P. 639- 644.
  31. Eastell R., Colwell A., Hampton L., Reeve J. Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis // J. Bone Miner. Res. — 1997. — V. 12. — P. 59-65.
  32. Colwell A., Russell R., Eastell R. Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption // Eur. J. Clin. Invest. — 1993. — V. 23. — P. 341- 349.
  33. Brixen K., Eriksen E.F. Seibel M.J., Robins S.P., Bilezikian J.P. eds. Validation of local and systemic markers of bone turnover. In: Dynamics of Bone and Cartilage Metabolism — San Diego: Academic Press, 1999. — P. 427-436.
  34. Halleen J.M., Alatalo S.L., Suominen H., Cheng S., Janckila A.J., Vaananen H.K. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption // J. Bone Miner. Res. — 2000. — V. 15. — P. 1337-1345.
  35. Halleen J.M., Karp M., Viloma S., et al. Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterisation of six monoclonal antibodies // J. Bone Miner. Res. — 1999. — V. 14. — P. 464-469.
  36. Berger Ch.E., Kroner A., Thomas E., Kristen K. H., Ogris E., Engel A. Comparison of Biochemical Markers of Bone Metabolism in Serum and Femur Aspirates // Clinical Orthopaedics & Related Research. — 2002 — Vol. 395 — P. 174-179.
  37. Harade S., Rodan G.A. Control of osteoblast function and regulation of bone mass // Nature. — 2003. — V. 423. — P. 349-355.
  38. Chiba S., Okada K., Lee K., Segre G.V., Neer R.M. Molecular analysis of defect healing in rat diaphyseal bone // J. Vet. Med. Sci. — 2001. — V. 63, № 6. — P. 603-608.
  39. Ivaska K.K., Gerdhem P., Akesson K., Garnero P., Obrant K.J. Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women // J. Bone Miner. Res. — 2007. — V. 22, № 8. — P. 1155-1164.
  40. Hoesel L.M., Wehr U., Rambeck W.A., Schnettler R., Heiss C. Biochemical bone markers are useful to monitor fracture repair // Clinical orthopaedics & Related Research. — 2005. — V. 440. — P. 226-232.
  41. Stoffel K., Engler H., Kuster M., Riesen W. Changes in biochemical markers after lower limb fractures // Clinical Chemistry — 2007. — Vol. 53, № 1. — P. 131-134.
  42. Deftos U. Bone protein and peptide assays in the diagnosis and management of skeletal disease // Clin. Chem. — 1991. — V. 37. — P. 1143-1148.
  43. Bowles S.A., Kurdy N., Davis A.M., France M.W., Marsh D.R. Serum osteocalcin, total and bone-specific alkaline phosphatase following isolated tibial shaft fracture // Ann. Clin. Biochem. — 1996. — V. 33. — P. 196-200.
  44. Emami A., Larsson A., Petren-Mallmin M., Larsson S. Serum bone markers after intramedullary fixed tibial fractures // Clin. Orthop. Relat. Res. — 1999. — V. 368. — P. 220-229.
  45. Obrant K.J., Ivaska K.K., Gerdhem P., Alatalo S.L., Pettersson K., Vaananen H.K. Biochemical markers of bone turnover are influenced by recently sustained fracture // Bone. — 2005. — V. 36. — P. 786-792.
  46. Veitch S.W., Findlay S.C., Hamer A.J., Blumsohn A., Eastell R., Ingle B.M. Changes in bone mass and bone turnover following tibial shaft fracture // Osteoporos Int. — 2006. — V. 17, № 3. — P. 364-372.
  47. Yu-Yahiro J.A., Michael R.H., Dubin N.H., Fox K.M., Sachs M., Hawkes W.G., et al. Serum and urine markers of bone metabolism during the year after hip fracture // J. Am. Geriatr. Soc. — 2001. — V. 49. — P. 877-883.
  48. Ingle B.M., Hay S.M., Bottjer H.M., Eastell R. Changes in bone mass and bone turnover following ankle fracture // Osteoporosis International. — 1999. — Volume 10, № 5. — Р 408-415.
  49. Nork, S.E. Fractures of the Shaft of the Femur. In: Bucholz R.W.; Heckman J.D.; Court-Brown C.M., editors. Rockwood and Green‘s Fractures in Adults. 6th ed. — Philadelphia (PA): Lippincott Williams & Wilkins, 2006. — P. 1845-1914.
  50. Court-Brown C.M., McQueen M.M. Nonunions of the proximal humerus: their prevalence and functional outcome // J. Trauma. — 2008. — V. 64, № 6. — P. 1517-1521.
  51. Giannoudis P.V., MacDonald D.A., Matthews S.J., Smith R.M., Furlong A.J., De Boer P. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs // J. Bone Joint Surg. Br. — 2000. — V. 82, № 5. — P. 655-658.
  52. Parker M.J., Raghavan R., Gurusamy K. Incidence of fracture-healing complications after femoral neck fractures // Clin. Orthop. Relat. Res. — 2007. — V. 458. — P. 175-179.
  53. Phieffer L.S., Goulet J.A. Delayed unions of the tibia // Instr. Course Lect. — 2006. — V. 55. — P. 389-401.
  54. Society C.O.T. Nonunion following intramedullary nailing of the femur with and without reaming. Results of a multicenter randomized clinical trial // J. Bone Joint Surg. Am. — 2003. — V. 85-A., № 11. — P. 2093-2096.
  55. Taitsman L.A., Lynch J.R., Agel J., Barei D.P., Nork S.E. Risk factors for femoral nonunion after femoral shaft fracture // J Trauma. — 2009. — V. 67, № 6. — P. 1389-1392.
  56. Ly T.V., Swiontkowski M.F. Treatment of femoral neck fractures in young adults // J. Bone Joint Surg. Am. — 2008. — V. 90, № 10. — P. 2254-2266.
  57. Yokoyama K., Itoman M., Uchino M., Fukushima K., Nitta H., Kojima Y. Immediate versus delayed intramedullary nailing for open fractures of the tibial shaft: A multivariate analysis of factors affecting deep infection and fracture healing // Indian. J. Orthop. — 2008. — V. 42, № 4. — P. 410-419.
  58. Foulk D.A., Szabo R.M. Diaphyseal humerus fractures: natural history and occurrence of nonunion // Orthopedics. — 1995. — V. 18, № 4. — P. 333-335.
  59. Lindsey R.W., Blair S.R. Closed tibial-shaft fractures: which ones benefit from surgical treatment? // J. Am Acad Orthop Surg. — 1996. — V. 4, № 1. — P. 35-43.
  60. Kyro A., Usenius J.P., Aarnio M., Kunnamo I., Avikainen V. Are smokers a risk group for delayed healing of tibial shaft fractures? // Ann. Chir. Gynaecol. — 1993. — V. 82, № 4. — P. 254-262.
  61. Kurdy N.M. Serology of abnormal fracture healing: the role of PIIINP, PICP, and BsALP // J. Orthop. Trauma. — 2000. — V. 14, № 1. — P. 48-53.
  62. Nyman M.T., Paavolainen P., Forsius S., Lamberg-Allardt C. Clinical evaluation of fracture healing by serum osteocalcin and alkaline phosphatase // Ann. Chir. Gynaecol. — 1991. — V. 80, № 3. — P. 289-293.
  63. Herrmann M., Klitscher D., Georg Th., Frank J., et al. Different kinetics of bone markers in normal and delayed fracture healing of long bones // Clinical Chemistry. — 2002. — V. 48, № 12. — Р. 2263-2266.
  64. Bowles S.A., Kurdy N., Davis A.M., France M.W., Marsh D.R. Serum osteocalcin, total and bone-specific alkaline phosphatase following isolated tibial shaft fracture // Ann. Clin. Biochem. — 1996. — V. 33. — P. 196-200.
  65. Laurer H.L., Hagenbourger O., Quast S., Herrmann W., Marzi I. Sequential changes and pattern of bone specific alkaline phosphatase after trauma // Eur. J. Trauma. — 2000. — V. 1. — P. 33-38.
  66. Southwood L.L., Frisbie D.D., Kawcak C.E., McIlwraith C.W. Evaluation of serum biochemical markers of bone metabolism for early diagnosis of nonunion and infected nonunion fractures in rabbits // Am. J. Vet. Res. — 2003. — V. 64, № 6. — P. 727-735.
  67. Komatsu D.E., Brune K.A., Liu H., Schmidt A.L., Han B., Zeng Q.Q., Yang X., Nunes J.S., Lu Y., Geiser A.G., Ma Y.L., Wolos J.A., Westmore M.S., Sato M. Longitudinal in vivo analysis of the regionspecific efficacy of parathyroid hormone in a rat cortical defect model // Endocrinology. — 2009. — V. 150, № 4. — P. 1570-1579.
  68. Klein P., Bail H. J., Schell H., Michel R., Amthauer H., Bragulla H., Duda G. N. Are bone turnover markers capable of predicting callus consolidation during bone healing? // Calcified Tissue International. — 2004. — V. 75, № 1. — P. 40-49.
  69. Somay-Rendu E., Munos F., Garnero P. et al. Identification of osteopenic women at high risk of fracture: the OFELY study. // J. Bone Miner. Res. — 2005. — Vol. 20, № 10. — Р 1813-1819.

Views

Abstract - 456

PDF (Russian) - 2375

Cited-By


PlumX

Dimensions


Copyright (c) 2012 Pobel E.A., Bengus L.M., Dedukh N.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies